CannaPharmaRX (CPMD) 10-Q2023 Q1 Quarterly report

Filed: 22 Sep 23, 2:51pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: adequate, Avenue, awaiting, banker, begun, British, cannabidiol, CBD, CDN, certainty, Certificate, certified, collaboration, collaborative, Columbia, compounded, construction, content, Cremora, decommissioned, detailed, Diagonal, dried, drying, essentially, expectedsometime, export, exterior, face, failed, farm, forecasted, fuel, furniture, gram, greenhouse, history, implicit, indoor, interior, Israeli, laboratory, Lending, lessee, lessor, lifetime, listing, maintenance, marijuana, Master, matrix, maximum, meet, methodology, minimum, modification, Okanagan, overdraft, packing, parcel, pe, penalty, percentage, Preliminary, produce, recommissioned, recovery, rental, retire, retired, room, saleable, satisfactory, similarly, strike, Sunniva, Supplementary, tetrahydrocannabinol, THC, Thirty, Treasury, trim, trimmed, unsecured

Removed: application, art, beginning, branded, calculation, cast, combine, debenture, declared, deferring, depreciation, description, devastating, disease, duration, dynamic, economy, eligible, estate, evaluating, existed, expedient, forthcoming, global, hindsight, hold, immaterial, inclusion, individual, influence, interim, internationally, inventory, investor, issuable, joint, lack, leading, legalized, licensing, magnitude, modified, national, nonrecurring, optional, Organization, outbreak, package, pandemic, permitted, practical, profitability, qualitative, quantitative, ramp, readied, real, realizable, reduced, registration, reserved, retained, Retooling, retroactively, ripple, role, situation, small, spread, St, stop, Suite, Targeted, transition, treated, ultimate, underway, updated, utilized, valid

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CPMD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO

18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report of CannaPharmaRx Inc. (the “Company”) on Form 10-Q for the three month period ended March 31, 2023, as filed with the Securities and Exchange Commission on September 22, 2023 (the “Report”), we, the undersigned, in the capacities and on the date indicated below, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

The Report fully complies with the requirements of Rule 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 22, 2023

/s/ Dean Medwid

Dean Medwid, Principal Executive Officer

Dated: September 22, 2023

/s/ John Cassels

John Cassels, Principal Financial Officer